ANDA 209369, held by Rhodes Pharms. Tapentadol Hydrochloride.
As of Nov 16, 2026, ANDA 209369 (Tapentadol Hydrochloride), held by Rhodes Pharms, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 14, 2017 | Original application | Tentative approval | None posted |
| Tapentadol Hydrochloride75MG · tablet;oral | Tapentadol Hydrochloride | None (tentative approval) |
| Tapentadol Hydrochloride100MG · tablet;oral | Tapentadol Hydrochloride | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters